Recent Finacing
Recent Raise
Dual Therapeutics develops small‑molecule cancer therapies that induce tumor cell death by modulating tumor suppressors KLF6 and FOXO1, with in vivo efficacy and IND planned, based in New York.
Focus Areas
Total Raised
Funding round